NF1 and malignant peripheral nerve sheath tumor: For patients, with neurofibromatosis type 1 (NF-1), the incidence of malignancy is significantly greater: 8–10% of NF-1 patients will develop an MPNST during their lifetimes, and nearly 50% of patients with MPNST have NF-1 [3].